About NAPRO TAX 260MG Injection
Jump on this hot deal with NAPRO TAX 260MG Injection-a top-tier, nanoparticle albumin-bound formulation designed for advanced cancer care. Manufactured by A year Pharmaceuticals Pvt. Ltd., this dazzling cytotoxic drug is strictly for hospital use and prescription only. Redeem monumental medical benefits as it targets breast, lung, and pancreatic cancer. The sterile single-dose vial contains Paclitaxel (260mg) in a clear, colorless to pale yellow solution. Enjoy prolonged shelf life of 24 months and secure export-quality standards. Don't miss this top-notch choice for oncology professionals.
Directions, Application & Use Type
NAPRO TAX 260MG Injection is strictly administered intravenously in hospital settings under medical supervision. Specially formulated for patients with breast, lung, or pancreatic cancer, this single-dose vial ensures precise, controlled dosing. The injection uses a nanoparticle albumin-bound technique for optimal efficacy, and it should never be frozen. Always follow the oncologist's direction of use to maximize safety and therapeutic impact. NAPRO TAX is exclusively intended for prescription-based, in-hospital administration only.
Domestic Market Presence & Payment Solutions
NAPRO TAX 260MG Injection caters to India's monumental domestic market as a high-value cytotoxic solution. The outlay is clearly mentioned on the packaging, reflecting its market value and commitment to affordability. Customers can benefit from flexible payment terms, making procurement convenient for healthcare providers. Prompt delivery is guaranteed with express shipping, ensuring timely supply to hospitals nationwide. It's the reliable choice for procurement managers prioritizing speed and product quality.
FAQ's of NAPRO TAX 260MG Injection:
Q: How should NAPRO TAX 260MG Injection be administered?
A: NAPRO TAX 260MG Injection should be administered intravenously by qualified healthcare professionals in a hospital setting. The dosage and infusion rate will be determined by the treating oncologist based on the patient's clinical condition.
Q: What cancers is NAPRO TAX 260MG Injection used to treat?
A: This injection is indicated for the treatment of breast cancer, lung cancer, and pancreatic cancer, utilizing a nanoparticle albumin-bound paclitaxel to enhance efficacy.
Q: When can the drug be ordered and what is the delivery timeline?
A: Orders for NAPRO TAX 260MG Injection can be placed at any time. Express shipping ensures swift delivery, with timelines depending on location and hospital requirements.
Q: Where can I store NAPRO TAX 260MG Injection safely?
A: Store the injection below 25C and never freeze it. Ensure it remains in its original packaging until use to maintain sterility and effectiveness.
Q: What are the main benefits of the nanoparticle albumin-bound formulation?
A: The nanoparticle albumin-bound design enhances drug delivery to tumor sites, potentially improving treatment outcomes and offering a more targeted therapy for cancer patients.
Q: Is a prescription required to purchase NAPRO TAX 260MG Injection?
A: Yes, as a cytotoxic drug intended strictly for hospital use, NAPRO TAX 260MG Injection can only be obtained with a valid prescription by authorized healthcare providers.